Latest Articles about THRX

Elan Provides Strategic Update - Analyst Blog

Zacks Equity Research — Wed, 22 May 2013 00:27:15 Z

Elan Corporation ( ELN ) recently provided an update on its strategic plans for the future. The company plans several acquisitions and has other strategic initiatives lined up for further

Seth Klarman Buys BP, AIG, Elan Corp, Sells News Corp., Oracle

GuruFocus — Wed, 15 May 2013 04:03:59 Z

Renowned value investor Seth Klarman just reported his first quarter portfolio. Seth Klarman buys BP, AIG, Elan Corp, Rovi Corp, Idenix Pharmaceuticals, Inc., Directv, sells News Corp,

Elan in Royalty Deal with THRX - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 01:06:44 Z

Elan Corporation ( ELN ) recently inked a deal with Theravance Inc. ( THRX ) to purchase a participation interest in potential future royalty payments for a one-time cash payment of

Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog

Zacks Equity Research — Tue, 14 May 2013 02:06:31 Z

GlaxoSmithKline ( GSK ) and partner Theravance, Inc. ( THRX ) recently announced that their chronic obstructive pulmonary disease (COPD) candidate, Breo Ellipta has received US Food and

Pre-Market Most Active for May 13, 2013 : BAC, NOK, THRX, TSLA, MCP, ASIA, SKM, PERI, TM, UNIS, TLK, SPIL

NASDAQ.com News — Mon, 13 May 2013 16:39:50 Z

The NASDAQ 100 Pre-Market Indicator is down -1.51 to 2,979.51. The total Pre-Market volume is currently 3,051,357 shares traded. The following are the most active stocks for the pre-market

Weekly CEO Sells Highlight: Texas Roadhouse Inc., Theravance Inc., AmerisourceBergen Corp. ...

alicet236 — Tue, 07 May 2013 02:23:28 Z

According to GuruFocus Insider Data , these are the largest CEO sales during the past week: Texas Roadhouse Inc., Theravance Inc., AmerisourceBergen Corp. and Nuance Communications Inc.

Weekly CFO Sells Highlight: THRX, BERY, IPG, PG, ZNGA, TSS

gurujx — Mon, 06 May 2013 01:21:04 Z

According to GuruFocus Insider Data , the largest CFO sells during the past week were: Theravance Inc., Berry Plastics Group Inc., Interpublic Group of Companies Inc., Procter &

Split News Overshadows Theravance's 1Q Loss - Analyst Blog

Zacks Equity Research — Sat, 27 Apr 2013 01:21:50 Z

Theravance Inc. 's ( THRX ) first quarter 2013 loss of 39 cents per share was in line with the loss pegged by the Zacks Consensus Estimate. The first quarter 2013 loss compared unfavorably

Mid-Morning Market Update: Markets Open Mixed, Chevron Profit Beats Estimates

Jake L'Ecuyer — Fri, 26 Apr 2013 18:20:48 Z

Following the market opening Friday, the Dow traded up 0.07 percent to 14,710.36 while the NASDAQ dropped 0.13 percent to 3,285.71. The S&P also fell, declining 0.01 percent to

FDA Panel Backs GSK/THRX's Drug - Analyst Blog

Zacks Equity Research — Fri, 19 Apr 2013 01:12:49 Z

GlaxoSmithKline ( GSK ) and partner Theravance Inc. ( THRX ) recently received a boost when the Pulmonary-Allergy Drugs Advisory Committee of the US Food and Drug Administration (FDA)

Mid-Afternoon Market Update: Fairway Group Rises on Successful IPO as Markets Fall Further

Jake L'Ecuyer — Thu, 18 Apr 2013 23:43:57 Z

Toward the end of trading Thursday, the Dow traded down 0.46 percent to 14,551.73 while the NASDAQ dropped 1.21 percent to 3,165.79. The S&P also fell, declining 0.56 percent to

Mid-Day Market Update: Ultratech Tumbles On Downbeat Results, Theravance Rises

Jake L'Ecuyer — Thu, 18 Apr 2013 21:11:30 Z

Midway through trading Thursday, the Dow traded down 0.44 percent to 14,553.73 while the NASDAQ dropped 0.90 percent to 3,175.79. The S&P also fell, declining 0.49 percent to 1,544.47.

Mid-Morning Market Update: Markets Go Red, PepsiCo Profit Beats Estimates

Jake L'Ecuyer — Thu, 18 Apr 2013 18:42:30 Z

Following the market opening Thursday, the Dow traded down 0.31 percent to 14,572.95 while the NASDAQ dropped 1.01 percent to 3,172.48. The S&P also fell, declining 0.70 percent to

Benzinga Market Primer: Thursday, April 18

Matthew Kanterman — Thu, 18 Apr 2013 14:33:48 Z

Futures Slightly Higher as G20 Agrees to Avoid Competitive Devaluations U.S. equity futures rose slightly in pre-market trading following the release of a draft G20 statement. In the statement,

GSK/THRX Drug to Face FDA Panel - Analyst Blog

Zacks Equity Research — Wed, 17 Apr 2013 01:00:01 Z

The US Food and Drug Administration (FDA) recently released briefing documents ahead of the review by its Pulmonary-Allergy Drugs Advisory Committee of the New Drug Application (NDA) of